Th FDA granted another 510(k) clearance to iRhythm Technologies for its AI-powered software system designed for use with Verily’s irregular pulse tracking watch. The clearance is for an algorithm that categorizes patients’ AFib by analyzing how much of it they experience over time.
Cardiologs is developing a new model to predict atrial fibrillation. A new study, sponsored by the Paris-based company, showed that the algorithm can accurately predict the near-term presence or absence of AFib using only the first 24 hours of a Holter device recording.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Paris-based Cardiologs has a software platform to screen for arrhythmias from ECG data. It would add to Philips' portfolio of cardiac software for hospitals and remote monitoring.
The digital health company filed a complaint with the Federal Trade Commission last week, seeking a ban on the import of the Apple Watch. AliveCor cited copyright violations related to Apple’s ECG feature as the reason for seeking the ban.
Hillrom will buy Bardy Diagnostics, a startup that makes a wearable ECG patch, for $375 million in cash.
The startup, which has developed a portable ECG device, received clearance for algorithms to detect more cardiac conditions, such as premature contractions.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Wearable devices are growing in importance for collecting data in trials, but their utility may vary based on patient demographics and disease state.
Earlier this year the company signed an exclusive distribution deal with Biotronik to expand access to the device.
Apple Watch's entry into the device world garnered a ton of attention and praise, but a good portion of observers have reservations about whether it will truly move the needle in healthcare.
Qardio's three products — QardioArm, QardioBase and QardioCore — have been integrated onto Tactio Health Group's digital platform.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
AliveCor Founder and CMO Dr. Dave Albert said that this opens the door to the NHS buying AliveCor devices for all 2 million atrial fibrillation patients in England "to save money and lives by preventing strokes."